Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment

SIMPLE SUMMARY: This study investigates the therapeutic efficacy of combining Metformin (MET) and Celecoxib (CXB) in the treatment of breast cancer. Niosomes, which are drug carriers, were prepared using the thin-film hydration technique. These niosomes were characterized and found to have stable pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Basheer, Haneen A., Alhusban, Maram A., Zaid Alkilani, Ahlam, Alshishani, Anas, Elsalem, Lina, Afarinkia, Kamyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605450/
https://www.ncbi.nlm.nih.gov/pubmed/37894371
http://dx.doi.org/10.3390/cancers15205004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605450/
https://www.ncbi.nlm.nih.gov/pubmed/37894371
http://dx.doi.org/10.3390/cancers15205004

Ejemplares similares